These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Cytochemical (icroscopic and quantitative) studies on cultured cells and biopsies of Burkitt's lymphoma. (Including a study of the effect of endoxanon lysosomal enzymes). Grillo TA Afr J Med Sci; 1971 Jan; 2(1):9-35. PubMed ID: 4328984 [No Abstract] [Full Text] [Related]
24. Second malignant clone underlying a Burkitt-tumor exacerbation. Fialkow PJ; Klein G; Clifford P Lancet; 1972 Sep; 2(7778):629-31. PubMed ID: 4116779 [No Abstract] [Full Text] [Related]
26. Analysis of haemopoiesis: the use of cell markers and in vitro culture techniques in studies of clonal haemopathies in man. Adamson JW Clin Haematol; 1984 Jun; 13(2):489-502. PubMed ID: 6380854 [TBL] [Abstract][Full Text] [Related]
27. Search for host defenses in Burkitt lymphoma: membrane immunofluorescence tests on biopsies and tissue culture lines. Klein G; Klein E; Clifford P Cancer Res; 1967 Dec; 27(12):2510-20. PubMed ID: 4866767 [No Abstract] [Full Text] [Related]
28. Use of cell culture in acute leukemia and Burkitt's tumor. Foley GE Cancer Res; 1967 Dec; 27(12):2471-8. PubMed ID: 4866764 [No Abstract] [Full Text] [Related]
29. Genetic markers as tracers in cell culture. Gartler SM Natl Cancer Inst Monogr; 1967 Sep; 26():167-95. PubMed ID: 4864103 [No Abstract] [Full Text] [Related]
30. Polycythemia vera: stem-cell and probable clonal origin of the disease. Adamson JW; Fialkow PJ; Murphy S; Prchal JF; Steinmann L N Engl J Med; 1976 Oct; 295(17):913-6. PubMed ID: 967201 [TBL] [Abstract][Full Text] [Related]
33. Reversion of tumorigenicity in an EBV-converted Burkitt's lymphoma line. Klein G Ciba Found Symp; 1989; 142():36-48; discussion 48-53. PubMed ID: 2545422 [TBL] [Abstract][Full Text] [Related]
34. Non-random X chromosome expression in female mules and hinnies. Hamerton JL; Richardson BJ; Gee PA; Allen WR; Short RV Nature; 1971 Jul; 232(5309):312-5. PubMed ID: 5094834 [No Abstract] [Full Text] [Related]
35. Burkitt lymphoma in a child with osteogenesis imperfecta. Choi SW; Wechsler DS Pediatr Blood Cancer; 2005 Nov; 45(6):863-4. PubMed ID: 15926161 [No Abstract] [Full Text] [Related]
36. Developmental implications of multiple tissue studies in glucose-6-phosphate dehydrogenase-deficient heterozygotes. Gandini E; Gartler SM; Angioni G; Argiolas N; Dell'Acqua G Proc Natl Acad Sci U S A; 1968 Nov; 61(3):945-8. PubMed ID: 5246558 [No Abstract] [Full Text] [Related]
37. [Electrophoretic and kinetic properties of erythrocyte glucose-6-phosphate dehydrogenase (Gd) in hereditary enzyme deficiency. A new variant of glucose-6-phosphate dehydrogenase : Gd Kremenchug]. Tokarev YN; Chernyak NB; Batishchev AI; Lamzina NV; Alexeyev GA Nouv Rev Fr Hematol (1978); 1978; 20(4):557-64. PubMed ID: 752149 [TBL] [Abstract][Full Text] [Related]
38. Burkitt's lymphoma: a review of the pathology, immunology, and possible etiologic factors. Wright DH Pathol Annu; 1971; 6():337-63. PubMed ID: 4342309 [No Abstract] [Full Text] [Related]
39. Tissue mosaics and clonal mechanisms of atherogenesis. Reiner JM Mech Ageing Dev; 1978 Jul; 8(1):15-20. PubMed ID: 692174 [TBL] [Abstract][Full Text] [Related]
40. [The diagnosis of glucose-6-phosphate dehydrogenase deficiency of the erythrocytes]. Marti HR Helv Med Acta; 1963 Nov; 30(4):667-71. PubMed ID: 5878836 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]